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Volume 51, Number 11S Abstracts 7Sinterposition aortic graft in WT mice. In some mice
Eph-B4 was stimulated with Ephrin-B2/Fc injected IP
every other day until harvest; other vein grafts were locally
treated with WT or mutated Eph-B4 coding adenovirus
(1.0x109 pfu). Vein grafts were harvested and analyzed
after 3-4 weeks.
Results: Stimulation of Eph-B4 with Ephrin-B2/Fc
limited wall thickness (0.03  0.01 mm vs 0.06  0.01
mm, n  5-7). Eph-B4 colocalized with cav-1 in sucrose
gradient separation and co-immunoprecipitation. Vein
grafts derived from cav-1-KO mice had increased wall
thickness (0.09 0.01 mm vs 0.05 0.01 mm, n 3-5).
Unlike WT grafts, Ephrin-B2/Fc treated Cav-1 KO vein
grafts did not have reduced wall thickness (0.09  0.01
mm, n  4). CBD mutated Eph-B4 was unable to phos-
phorylate tyrosine in vitro; adenovirus incorporating the
CBD mutated Eph-B4 did not limit vein graft wall thick-
ness compared to reduced wall thickness with WT Eph-B4
adenovirus (0.09  0.01 mm vs 0.06  0.01 mm, n  6).
Conclusions: Eph-B4 is functional in adult veins and
actively limits vein graft wall thickening during adaptation
to the arterial environment. Caveolin-1 may act as the shear
stress sensor for Eph-B4, suggesting that the Eph-B4-
caveolin-1 pathway may be a therapeutic target to improve
vein graft patency.
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Objectives: To determine the cerebrovascular risk
stratification potential of degree of stenosis, clinical features
and ultrasonic plaque characteristics in patients with asymp-
tomatic internal carotid artery (ICA) stenosis.
Methods: In this prospective, multicentre, cohort
study, 1121 patients with 50-99% asymptomatic ICA ste-
nosis in relation to the bulb (ECST) undergoing medical
intervention were followed-up for 6-98 (mean 48) months.
Hazard ratios for ICA stenosis, clinical features and ultra-
sonic plaque texture features associated with ipsilateral
cerebrovascular or retinal ischemic (CORI) events werecalculated using univariate analysis and Cox proportional
hazard models.
Results: During follow-up, a total of 130 CORI events
including 59 strokes occurred. Severity of stenosis, smok-
ing history of more than 10 pack-years, systolic blood
pressure, history of contralateral TIA or stroke, low gray
scale median (GSM), increased plaque area, plaque types 1,
2 and 3, and presence of discrete white areas without
acoustic shadowing (DWA) were associated with increased
risk. The area under the curve in ROC curves for stenosis,
stenosis combined with clinical features and stenosis com-
bined with clinical features and plaque features was 0.59,
0.66 and 0.82 respectively. In a Cox proportional hazard
model, stenosis, history of contralateral TIA or stroke,
GSM, plaque area and DWA were independent predictors
of stroke. Of the 923 patients with 70 % stenosis ( 50%
NASCET) 5-year stroke rates less than 5%were predicted in
524, 5-9% in 149, 10-19% in 176, 20-29% in 40 and rates
equal or greater than 30% in 34 patients.
Conclusions: Cerebrovascular risk stratification is pos-
sible using a combination of clinical and ultrasonic plaque
features. These finding can be used to refine the indications
for carotid endarterectomy. However, they need to be
validated in additional prospective studies or the medical
arm of future randomized controlled trials of medical vs
surgical or endovascular therapy.
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Objectives: Increasing data are suggesting that statins
can significantly decrease cardiovascular and cerebrovascu-
lar events due to a plaque stabilization effect. However, the
benefit of statins in patients undergoing carotid angioplasty
and stenting (CAS) for carotid stenosis is not well defined.
Aim of this study was to investigate whether statins use was
associated with decreased perioperative and late risks of
stroke, mortality and restenosis in patients undergoing
CAS.
